Advertisement
Advertisement
U.S. markets open in 8 hours 32 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
113.11-0.57 (-0.50%)
At close: 04:00PM EST
113.00 -0.11 (-0.10%)
After hours: 05:22PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close113.68
Open114.59
Bid0.00 x 800
Ask0.00 x 900
Day's Range112.64 - 115.88
52 Week Range102.01 - 219.75
Volume196,636
Avg. Volume141,108
Market Cap1.89B
Beta (5Y Monthly)1.01
PE Ratio (TTM)27.96
EPS (TTM)4.05
Earnings DateFeb 01, 2022 - Feb 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 02, 2010
1y Target Est211.71
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LGND

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ligand Pharmaceuticals Incorpor
    LGND: Lowering target price to $127.00LIGAND PHARMACEUTICALS has an Investment Rating of BUY; a target price of $127.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
Advertisement
Advertisement